131 related articles for article (PubMed ID: 21419474)
21. Vimentin expression is associated with decreased survival in gastric cancer.
Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
Chen C; Chen LQ; Chen LD; Yang GL; Li Y
Hepatogastroenterology; 2008; 55(84):991-7. PubMed ID: 18705314
[TBL] [Abstract][Full Text] [Related]
23. Serum interleukin-12 levels in patients with gastric cancer.
Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
[TBL] [Abstract][Full Text] [Related]
24. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis.
Miyagawa K; Sakakura C; Nakashima S; Yoshikawa T; Fukuda K; Kin S; Nakase Y; Shimomura K; Oue N; Yasui W; Hayasizaki H; Okazaki Y; Yamagishi H; Hagiwara A; Otsuji E
Anticancer Res; 2008; 28(2B):1169-79. PubMed ID: 18505053
[TBL] [Abstract][Full Text] [Related]
26. Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II.
Eom DW; Kang GH; Han SH; Cheon GJ; Han KH; Oh HS; Kim JH; Jang HJ; Hong SM
Am J Surg Pathol; 2011 Jan; 35(1):84-91. PubMed ID: 21164291
[TBL] [Abstract][Full Text] [Related]
27. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
28. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.
Chan AO; Chu KM; Lam SK; Wong BC; Kwok KF; Law S; Ko S; Hui WM; Yueng YH; Wong J
J Clin Oncol; 2003 Jun; 21(12):2288-93. PubMed ID: 12805328
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
Zhao ZS; Chu YQ; Ye ZY; Wang YY; Tao HQ
Hum Pathol; 2010 May; 41(5):686-96. PubMed ID: 20060156
[TBL] [Abstract][Full Text] [Related]
30. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
31. Investigation of serum tumor markers in the diagnosis of gastric cancer.
Fan B; Xiong B
Hepatogastroenterology; 2011; 58(105):239-45. PubMed ID: 21510322
[TBL] [Abstract][Full Text] [Related]
32. [Correlation of preoperative plasma levels of big endothelin-1 to prognosis of gastric carcinoma].
Teng XJ; Liu R; Zhang ZX; He JF; Shen ZX
Ai Zheng; 2008 Jan; 27(1):88-91. PubMed ID: 18184472
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer.
Dilege E; Mihmanli M; Demir U; Ozer K; Bostanci O; Kaya C; Aksakal O; Sakiz D
Hepatogastroenterology; 2010; 57(99-100):674-7. PubMed ID: 20698248
[TBL] [Abstract][Full Text] [Related]
34. Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis.
Ishii T; Fujiwara Y; Ohnaka S; Hayashi T; Taniguchi H; Takiguchi S; Yasuda T; Yano M; Monden M
Ann Surg Oncol; 2004 Aug; 11(8):778-85. PubMed ID: 15289240
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
36. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
37. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
38. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.
Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ
Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863
[TBL] [Abstract][Full Text] [Related]
39. Protein expression of osteopontin in tumor tissues is an independent prognostic indicator in gastric cancer.
Dai N; Bao Q; Lu A; Li J
Oncology; 2007; 72(1-2):89-96. PubMed ID: 18004082
[TBL] [Abstract][Full Text] [Related]
40. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
